Health and Lifestyle
NAFDAC Approves Malaria R21 Vaccine for use
Iyojo Ameh
The National Agency for Food and Drug Administration and Control (NAFDAC) says the agency has approved the provisional use of the R21 malaria vaccine.
The Director General of the Agency Professor Mojisola Adeyeye stated this while briefing newsmen in Abuja.
The R21 Malaria vaccine is an adjuvanted protein vaccine presented as a sterile solution.
Professor Adeyeye confirmed that the vaccine has passed through the rigorous test in line with global standards, and the outcome of the tests was satisfactory, before the approval for use
Prof.
She told Newsmen that Nigeria expects to get at least 100,000 doses of the new vaccine in donations before the market authorisation.